Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:cyclosporin A
go back to main search page
Accession:CHEBI:4031 term browser browse the term
Definition:A cyclic nonribosomal peptide of eleven amino acids; an immunosuppressant drug widely used in post-allogeneic organ transplant to reduce the activity of the patient's immune system, and therefore the risk of organ rejection. Also causes reversible inhibition of immunocompetent lymphocytes in the G0- and G1-phase of the cell cycle.
Synonyms:exact_synonym: 30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
 related_synonym: (R-[R*,R*-(E)])-Cyclic(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-alpha-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl);   1,11-cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(E)-(2S,3R,4R)-2-amino-3-hydroxy-N,4-dimethyloct-6-enoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucine];   30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;   Antibiotic S 7481F1;   Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl)-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl);   Cyclosporine;   Formula=C62H111N11O12;   Gengraf;   InChI=1S/C62H111N11O12/c1-25-27-28-40(15)52(75)51-56(79)65-43(26-2)58(81)67(18)33-48(74)68(19)44(29-34(3)4)55(78)66-49(38(11)12)61(84)69(20)45(30-35(5)6)54(77)63-41(16)53(76)64-42(17)57(80)70(21)46(31-36(7)8)59(82)71(22)47(32-37(9)10)60(83)72(23)50(39(13)14)62(85)73(51)24/h25,27,34-47,49-52,75H,26,28-33H2,1-24H3,(H,63,77)(H,64,76)(H,65,79)(H,66,78)/b27-25+/t40-,41+,42+,43-,44+,45-,46+,47+,49+,50-,51+,52-/m1/s1;   InChIKey=PMATZTZNYRCHOR-CGLBZJNRSA-N;   Neoral;   SMILES=CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\\C=C\\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C;   Sandimmune;   ciclosporin;   ciclosporina;   ciclosporine;   ciclosporinum
 alt_id: CHEBI:63586;   CHEBI:91802
 xref: Beilstein:3647785 "Beilstein";   CAS:59865-13-3 "ChemIDplus";   CAS:59865-13-3 "KEGG COMPOUND";   DrugBank:DB00091;   Drug_Central:760 "DrugCentral";   KEGG:C05086;   KEGG:D00184;   KNApSAcK:C00001517;   LINCS:LSM-1703
 xref_mesh: MESH:D016572
 xref: PMID:11058832 "Europe PMC";   PMID:11069928 "Europe PMC";   PMID:11079273 "Europe PMC";   PMID:11080188 "Europe PMC";   PMID:11238591 "Europe PMC";   PMID:11256490 "Europe PMC";   PMID:11278005 "Europe PMC";   PMID:11315347 "Europe PMC";   PMID:11370709 "Europe PMC";   PMID:11406057 "Europe PMC";   PMID:11426833 "Europe PMC";   PMID:11442023 "Europe PMC";   PMID:11481617 "Europe PMC";   PMID:11493684 "Europe PMC";   PMID:11529914 "Europe PMC";   PMID:11557554 "Europe PMC";   PMID:11564166 "Europe PMC";   PMID:11676831 "Europe PMC";   PMID:11870366 "Europe PMC";   PMID:12021257 "Europe PMC";   PMID:12050171 "Europe PMC";   PMID:12603598 "Europe PMC";   PMID:12761440 "Europe PMC";   PMID:12929192 "Europe PMC";   PMID:12950728 "Europe PMC";   PMID:14521916 "Europe PMC";   PMID:14621732 "Europe PMC";   PMID:14638917 "Europe PMC";   PMID:14672695 "Europe PMC";   PMID:14682659 "Europe PMC";   PMID:14743390 "Europe PMC";   PMID:15030555 "Europe PMC";   PMID:15175101 "Europe PMC";   PMID:15210365 "Europe PMC";   PMID:15306697 "Europe PMC";   PMID:15383526 "Europe PMC";   PMID:15541012 "Europe PMC";   PMID:15613074 "Europe PMC";   PMID:15626898 "Europe PMC";   PMID:15657176 "Europe PMC";   PMID:1566062 "Europe PMC";   PMID:15711594 "Europe PMC";   PMID:15811524 "Europe PMC";   PMID:15962181 "Europe PMC";   PMID:16372476 "Europe PMC";   PMID:16404634 "Europe PMC";   PMID:16724420 "Europe PMC";   PMID:16801218 "Europe PMC";   PMID:16898534 "Europe PMC";   PMID:17032751 "Europe PMC";   PMID:17083576 "Europe PMC";   PMID:17117422 "Europe PMC";   PMID:17192032 "Europe PMC";   PMID:17220244 "Europe PMC";   PMID:17229932 "Europe PMC";   PMID:17265451 "Europe PMC";   PMID:17446460 "Europe PMC";   PMID:17603747 "Europe PMC";   PMID:18076075 "Europe PMC";   PMID:18171316 "Europe PMC";   PMID:18191430 "Europe PMC";   PMID:18217899 "Europe PMC";   PMID:18259730 "Europe PMC";   PMID:18299432 "Europe PMC";   PMID:18359899 "Europe PMC";   PMID:18583716 "Europe PMC";   PMID:18597363 "Europe PMC";   PMID:18790203 "Europe PMC";   PMID:18818682 "Europe PMC";   PMID:18931077 "Europe PMC";   PMID:18975184 "Europe PMC";   PMID:19282398 "Europe PMC";   PMID:19589783 "Europe PMC";   Patent:US4117118;   Reaxys:3647785 "Reaxys";   VSDB:1765;   Wikipedia:Ciclosporin


show annotations for term's descendants       view all columns           Sort by:
 





Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 23754
    role 23643
      biological role 23606
        biochemical role 22955
          metabolite 22847
            cyclosporin A 8740
              cyclosporin A derivative + 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 23754
    subatomic particle 23703
      composite particle 23703
        hadron 23703
          baryon 23703
            nucleon 23703
              atomic nucleus 23703
                atom 23703
                  main group element atom 23522
                    p-block element atom 23522
                      carbon group element atom 23232
                        carbon atom 23208
                          organic molecular entity 23208
                            organic group 21897
                              organic divalent group 21869
                                organodiyl group 21869
                                  carbonyl group 21840
                                    carbonyl compound 21840
                                      carboxylic acid 20885
                                        carboacyl group 18982
                                          univalent carboacyl group 18982
                                            carbamoyl group 18370
                                              carboxamide 18370
                                                peptide 9768
                                                  cyclic peptide 9177
                                                    homodetic cyclic peptide 8768
                                                      cyclosporin A 8740
                                                        cyclosporin A derivative + 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.